Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kathleen F. Sullivan is active.

Publication


Featured researches published by Kathleen F. Sullivan.


Developmental Medicine & Child Neurology | 2008

THE EPIDEMIOLOGY OF GERMINAL MATRIX HEMORRHAGE DURING THE FIRST HALF‐DAY OF LIFE

Alan Leviton; Marcelfo Pagano; Karl Kuban; Kalpathy S. Krishnamoorthy; Kathleen F. Sullivan; Elizabeth N. Allred

The personal and maternal characteristics of 27 babies with early‐onset germinal matrix hemorrhage (EGMH) were compared with those of 280 babies with normal cranial ultrasonograms, studied in a separate clinical trial. None of the mothers of the babies with EGMH had high blood pressure or pre‐eclampsia during pregnancy. Gestational age <30 weeks and initial pH <7·2 indicated increased risks of EGMH, and maternal receipt of steroids indicated reduced risk of EGMH. Thus prenatal and immediately perinatal factors appear to convey much of the information about the risk of EGMH.


Obstetrical & Gynecological Survey | 1996

Persistent Pulmonary Hypertension of the Newborn and Smoking and Aspirin and Nonsteroidal Antiinflammatory Drug Consumption During Pregnancy

Linda J. Van Marter; Alan Leviton; Elizabeth N. Allred; Marcello Pagano; Kathleen F. Sullivan; Aaron Cohen; Michael F. Epstein

OBJECTIVE Prenatal causation of persistent pulmonary hypertension of the newborn (PPHB) is suggested by a specific pattern of pulmonary vascular remodeling observed immediately after birth in some infants with fatal PPHN. The goal of this study was to determine whether PPHN is associated with fetal exposure to: (1) tobacco and marijuana smoking (ie, contributors to fetal hypoxemia), (2) consumption of aspirin and other nonsteroidal antiinflammatory drugs (ie, inhibitors of prostaglandin synthesis), and (3) cocaine use (ie, a contributor to vasospasm). DESIGN Case-control interview study. SETTING Two Harvard-affiliated newborn intensive care units. PARTICIPANTS Mothers of case infants who had PPHN or who met criteria for the referent group. INTERVENTIONS During July 1985 through April 1989, we interviewed mothers of 103 infants with PPHN and 298 control infants. Because of potential selection bias that might result from recruiting only inborn control infants even though two-thirds of cases were outborn, separate analyses compared the 103 total and 35 inborn infants with PPHN with the 298 inborn control infants. Multivariate analyses were used to adjust for potential confounding factors, including maternal education and Medicaid health insurance (ie, two markers of socioeconomic status), other antenatal factors found to be associated with PPHN (ie, maternal urinary tract infection and diabetes mellitus), and the infants sex. MAIN OUTCOME MEASURES Self-reported use or consumption of tobacco, marijuana, cocaine, aspirin, and other nonsteroidal antiinflammatory drugs during pregnancy. RESULTS The adjusted odds ratios (and 95% confidence intervals) for maternal pregnancy exposures to the factors of principal interest among the total study population were: aspirin, 4.9 (1.6-15.3); and nonsteroidal antiinflammatory drugs, 6.2 (1.8-21.8); for the inborn group they were aspirin, 9.6 (2.4-39.0); and nonsteroidal antiinflammatory drugs, 17.5 (4.3-71.6). Although the association between tobacco smoking during pregnancy and PPHN was elevated in univariate analyses, with odds ratios (and 95% confidence intervals) of 2.0 (1.2-3.4) and 1.3 (0.6-3.3) for total and inborn populations, respectively, the relationship was not significant after adjustment for all other factors in the final logistic regression model. Acknowledged illicit drug use was too infrequent (3.2%) to evaluate. CONCLUSION Maternal consumption of nonsteroidal antiinflammatory drugs and aspirin during pregnancy or the reasons these drugs were ingested seem to contribute to an increased risk of PPHN.


Pediatrics | 1986

Neonatal Intracranial Hemorrhage and Phenobarbital

Karl Kuban; Alan Leviton; Kalpathy S. Krishnamoorthy; Elizabeth R. Brown; Rita L. Teele; Jenny A. Baglivo; Kathleen F. Sullivan; Kenneth Huff; Susan White; Robert H. Cleveland; Elizabeth N. Allred; Karen L. Spritzer; Helen N. Skouteli; Paul Cayea; Michael F. Epstein


Pediatrics | 1990

Periventricular-Intraventricular Hemorrhage Sonographic Localization, Phenobarbital, and Motor Abnormalities in Low Birth Weight Infants

Kalpathy S. Krishnamoorthy; Karl Kuban; Alan Leviton; Elizabeth R. Brown; Kathleen F. Sullivan; Elizabeth N. Allred


Pediatrics | 1988

Hemorrhage, Phenobarbital, and Fluctuating Cerebral Blood Flow Velocity in the Neonate

Karl Kuban; Helen N. Skouteli; Allen Cherer; Elizabeth R. Brown; Alan Leviton; Marcello Pagano; Elizabeth N. Allred; Kathleen F. Sullivan


Journal of Perinatology | 1988

Arterial blood gas derangements associated with death and intracranial hemorrhage in premature babies.

Helen N. Skouteli; Karl Kuban; Alan Leviton; Elizabeth R. Brown; Kalpathy S. Krishnamoorthy; Marcello Pagano; Elizabeth N. Allred; Kathleen F. Sullivan; Jenny A. Baglivo; Kenneth Huff


JAMA Pediatrics | 1987

Respiratory Complications in Low-Birth-Weight Infants Who Received Phenobarbital

Karl Kuban; Alan Leviton; Elizabeth R. Brown; Kalpathy S. Krishnamoorthy; Jenny A. Baglivo; Kathleen F. Sullivan; Elizabeth N. Allred


Pediatrics | 1988

Bilirubin, Intraventricular Hemorrhage, and Phenobarbital in Very Low Birth Weight Babies

Michael F. Epstein; Alan Leviton; Karl Kuban; Marcello Pagano; Catherine Meltzer; Helen N. Skouteli; Elizabeth R. Brown; Kathleen F. Sullivan


Pediatric Research | 1985

1380 REDUCED INCIDENCE OF HYPERBILIEDBINEMIA IN LOW BIRTHWEIGHT BABIES RECEIVING PHENOBAHBITAL

Michael F. Epstein; Karl Kuban; Helen Skoutelli; Katherine Ifeltzer; Elizabeth R. Brown; K S Krishnarooorthy; Kathleen F. Sullivan; Alan Levi Ton


Pediatrics | 1989

In Reply: Hemorrhage, Phenobarbital, and Fluctuating Cerebral Blood Flow

Karl Kuban; Alan Leviton; Kathleen F. Sullivan; Helen Skoutelli; Marcello Pagano

Collaboration


Dive into the Kathleen F. Sullivan's collaboration.

Top Co-Authors

Avatar

Alan Leviton

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Elizabeth R. Brown

Fred Hutchinson Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Linda J. Van Marter

Brigham and Women's Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge